Cafe Move: A Novel Program for Prevention of Age-Related Physical Frailty

这项研究的主要目标是获得初步数据，以支持未来的R01级调查。这项未来试验的重点将是检查我们在试点工作中开发的一种预防身体虚弱的新方法的有效性：CAFéMove。CaféMove使用简单但强大的力量、机动性和平衡性评估，使人们能够快速轻松地了解他们的身体功能，相对于标准数据(考虑年龄、身高等)。所有的CaféMove评估都可以在正式的医疗保健环境之外(例如，在一个人的家里)进行，从而促进了自主性，减少了准入障碍。在这项研究中，我们计划通过三种方式(“就餐”、“售货亭”和“送货”)在选定的独立居住的老年社区提供CaféMove。“就餐”选项将包括在预定的社区活动中进行面对面的评估。“Kiosk”选项将通过社区内当地托管的CaféMove站点提供，类似于当地药店的血压检查站；受过培训的人员就在附近，但人们可以自己与平台互动。最后，“送货”选项将允许人们订购(廉价的)评估用品，并在自己的家中进行测量。我们将进行一项双基线队列研究，目的是产生必要的数据，以计算感兴趣的结果指标的站点内和站点间的差异(例如，健康行为、预防策略的参与率)，这将为R01水平试验的设计提供信息。

The primary goal of this study is to acquire preliminary data to support a future R01-level investigation. The focus of this future trial will be to examine the efficacy of a novel approach to preventing physical frailty, which we have developed in our pilot work: Café Move. Café Move uses simple yet robust assessments of strength, mobility and balance to enable people to quickly and easily gain insight to their physical function, relative to normative data (accounting for age, height, etc.). All of the Café Move assessments can be performed outside of formal healthcare settings (e.g., in a person’s home), thus promoting autonomy and reducing barriers to access. In this study, we plan to make Café Move available in select independent-living senior communities via three modalities (“dine-in,” “kiosk,” and “delivery”). The “dine-in” option will involve face-to-face assessments at scheduled community events. The “kiosk” option will be available via Café Move stations hosted locally within the community, analogous to a blood pressure check station at the local drug store; trained personnel are nearby, but people can interact with the platform on their own. Finally, the “delivery” option will allow people to order the (inexpensive) assessment supplies and perform measurements in their own home. We will conduct a double-baseline cohort study intended to yield the data necessary to calculate within- and between-site variance in the outcome measures of interest (e.g., health behaviors, rates of engagement with prevention strategies), which will inform the design of an R01-level trial.